Navigation Links
Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer

IRVING, Texas--(BUSINESS WIRE)--Apr 25, 2007 - Reata Pharmaceuticals, Inc. today announced the publication of a review article covering the company's Synthetic Triterpenoid programs in the May 2007 issue of the prestigious journal "Nature Reviews Cancer."

The article, "Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer," by researchers and Reata scientific collaborators from the Dartmouth Medical School Karen T. Liby, Mark M. Yore and Michael B. Sporn, focuses on two new classes of multifunctional drugs that it reports can prevent and treat cancer in experimental animals. One of Reata's lead clinical candidates, from one of the classes the article describes, the Synthetic Triterpenoids, is entering advanced clinical trials for deadly, late-stage cancers.

The article describes the Synthetic Triterpenoids as a new class of non-toxic and highly multifunctional drugs that have applications for the prevention and treatment of not only cancer, but also of many other diseases with an inflammatory component.

"An outstanding body of work is emerging on the Synthetic Triterpenoids from many top academic collaborators," commented Warren Huff, Reata's CEO. "Dr. Sporn and his team have provided an excellent summary of the broad research currently underway on these compounds and the underlying biological pathways they modulate. Reata is delighted to have the opportunity to collaborate with these researchers in taking take these important new drugs forward to provide a clinical benefit for patients with cancer and other diseases."

Reata in-licensed the complete series of Synthetic Triterpenoids from Dartmouth and the University of Texas M.D. Anderson Cancer Center in 2004. RTA 402, the lead agent from this series, has recently begun Phase 2 clinical studies for cancer and anti-inflammatory diseases. An ongoing Phase 1 study in cancer patients has demonstrated
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Positive Statistical Analysis from Synthetic Bloods Oxycyte Traumatic Brain Injury Trial Indicates Achievement of Primary Endpoint
2. Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR
3. Targeting Specific Mutations Reveals Promising New Approach to Treating Genetic Disorders; Preclinical Data Published in Nature
4. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
5. Critical Therapeutics Announces the Publication of New Preclincial HMGB1 Data in Nature Immunology
6. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
7. Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
8. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
9. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
10. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
11. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Reata Synthetic Triterpenoids Profiled Nature Reviews Cancer
(Date:3/2/2015)... , March 2, 2015 When someone gets ... head to a primary care physician or an urgent ... majority of the healthcare provided by doctors and medical ... works, but it,s not ideal in every circumstance. Though ... actually locations where occupants have higher chances of contracting ...
(Date:3/2/2015)...  Akron Children,s Hospital has been designated a Diagnostic ... of Radiology (ACR), making it the first hospital in ... hospital in the United States ... from the ACR as a DICOE provides validation that ... with national benchmarks," says Dr. Michael Rubin , ...
(Date:3/2/2015)... HOUSTON, TX , March 2, 2015 ... (TSX-V: EPI) today reported financial results for the first ... unless specified otherwise, are expressed in Canadian dollars and ... Summary Results ESSA recorded ... share) for the three months ended December 31, 2014 ...
Breaking Medicine Technology:House Call Medicine Helps Patients Receive Treatment While Avoiding the Hassles and Potential Risks of an Urgent Care Facility 2Akron Children's designated ACR Diagnostic Imaging Center of Excellence 2ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 2ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 3ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 4
(Date:3/3/2015)... Motion Graphics artist at ... new plugin FCPX3D Confetti designed exclusively for Final Cut ... using confetti particles inside FCPX,” said Christina Austin, CEO ... transition, users will have fun as they choose, drag, ... clip to the next with 3D tumbling or exploding ...
(Date:3/2/2015)... 2015 Formetco today announced the official ... The FTX uses state-of-the-art technology to deliver an outdoor ... owner satisfaction. An item of particular value, and ... 10 year LED Brightness Warranty. , Why the FTX ... superior billboard among any other billboard product in the ...
(Date:3/2/2015)... Boston/Framingham (PRWEB) March 02, 2015 Getting ... freezer section is the goal this March as the ... was designated by the National Frozen & Refrigerated Foods ... food offers. Ian’s offers more than 20 delicious frozen ... exciting month. , The tasty frozen options are crafted ...
(Date:3/2/2015)... Mirena IUD lawsuits ( http://www.mirenalawsuit2014.com/ ) ... by the long-acting birth control device continue to move ... according to Bernstein Liebhard LLP. In an Order ... on February 24th, the Court ruled that a Mirena ... pursue her lawsuit, which accuses Bayer Healthcare Pharmaceuticals of ...
(Date:3/2/2015)... Cutler Integrative Medicine a leader in ... gives cutting-edge tips to bring about self-renewal. A 30 ... body by first cleaning house. According to Dr. ... all Toxic.” Between environmental toxins like heavy metals, people’s ... our high stress levels, we all have a level ...
Breaking Medicine News(10 mins):Health News:A new Confetti Generator entitled FCPX3D Confetti was released today from Pixel Film Studios for Final Cut Pro X 2Health News:Formetco Launches Innovative LED Billboard System 2Health News:Take a Fresh Look at Frozen with Ian’s 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Court’s Decision to Allow Certain Claims to Stand in Mirena Injury Case 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Court’s Decision to Allow Certain Claims to Stand in Mirena Injury Case 3Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Court’s Decision to Allow Certain Claims to Stand in Mirena Injury Case 4Health News:Skin and Wellness Power Couple give Quick Tips to Self-Renewal for Spring 2
... the third of five papers in the PLoS Medicine ... Africa, Sara Bennett and Freddie Ssengooba this week discuss the ... from Johns Hopkins University in Baltimore USA, and Dr Ssengooba ... basis for improving maternal, newborn, and child health (MNCH) in ...
... induce specific epigenetic changes and gene mutations that may be ... online study published June 29 in the Journal of ... a risk factor for colorectal cancer, with a recent meta-analysis ... past are 18% more likely to develop colorectal cancer than ...
... TUESDAY, June 29 (HealthDay News) -- Intensive control of ... disease for those with long-term type 2 diabetes who are ... it may have some other benefits, a new analysis suggests. ... a certain group of patients may slow progression of eye ...
... ... for employers who want to provide health benefits and control costs., , ... Minneapolis, MN (PRWEB) June 29, ... the largest independent insurance and employee benefits brokers in the Midwest, to offer customized ...
... use has decreased drastically over the last few decades, we ... Physicians (ACP) President, J. Fred Ralston, Jr., MD, FACP, said ... In Tobacco Control and Prevention, ACP called for a comprehensive ... actions being taken by states currently. "A comprehensive tobacco ...
... Ohio State University Comprehensive Cancer Center-Arthur G. James ... (OSUCCC-James) have discovered how a substance that is ... block the proliferation of cancer cells. Compelling ... have anticancer effects and other health benefits, the ...
Cached Medicine News:Health News:Smoking-related colorectal cancer in older women is associated with molecularly-defined DNA changes 2Health News:Tight Blood Sugar Control in Older Diabetics May Not Reduce Heart Risk 2Health News:Tight Blood Sugar Control in Older Diabetics May Not Reduce Heart Risk 3Health News:Bloom Health and Christensen Group Partner Together to Deliver Innovative Solution 2Health News:Internists outline comprehensive federal strategy to control tobacco use 2Health News:Study shows how dietary supplement may block cancer cells 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: